LEE M. ELLIS, M.D.
Radiology at Holcombe Blvd, Houston, TX
License number
Texas H9323
Category
Radiology
Type
Surgical Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about LEE M. ELLIS at radaris.comName
Address
Phone
537 Hide A Way Ln E, Hideaway, TX 75771
552 Lakeview Cir, New Braunfels, TX 78130
5349 Contender Ln, Fort Worth, TX 76132
5300 Mercer St UNIT 9, Houston, TX 77005
610 Maydelle Ln, Garland, TX 75042
Organization information
See more information about LEE M. ELLIS at bizstanding.comLee M Ellis MD
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
Categories:
Oncology Physicians & Surgeons
Phone:
(713) 792-6161 (Phone)
Professional information
See more information about LEE M. ELLIS at trustoria.com
Professor Of Molecular And Cellular Oncology At Md Anderson Cancer Center
Professor Of Molecular And Cellular Oncology At Md Anderson Cancer Center
Position:
Professor of Molecular and Cellular Oncology at MD Anderson Cancer Center, Professor of Surgery at MD Anderson Cancer Center, Vice Chair, Translational Medicine at SWOG, Chair, Cancer Research Committee at American Society of Clinical Oncology, Vice Chair, NCI Colon Cancer Task Force of the GI Cancers Steering Committee at National Cancer Institute, Member, Nominating Committee at American Society of Clinical Oncology
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
MD Anderson Cancer Center
since Jul 2013
-
Professor of Molecular and Cellular Oncology
MD Anderson Cancer Center
since Oct 1993
-
Professor of Surgery
SWOG
since May 2013
-
Vice Chair, Translational Medicine
American Society of Clinical Oncology
since Jun 2012
-
Chair, Cancer Research Committee
National Cancer Institute
since Jan 2012
-
Vice Chair, NCI Colon Cancer Task Force of the GI Cancers Steering Committee
American Society of Clinical Oncology
since Mar 2013
-
Member, Nominating Committee
MD Anderson Cancer Center
2010 - Jul 2013
-
Director, Colorectal Cancer Translational Research Program
MD Anderson Cancer Center
Oct 1993 - Jul 2013
-
Professor of Surgery and Cancer Biology
MD Anderson Cancer Center
Oct 2010 - Jun 2012
-
Director, Metastasis Research Center
MD Anderson Cancer Center
Jun 2008 - Jun 2012
-
Chair, Ad Interim, Department of Cancer Biology
University of Florida
1983 - 1990
-
Surgery residency
Education:
University of Virginia School of Medicine 1979 - 1983
MD
MD
Interests:
The Beatles, tennis, not destroying our earth, helping people, dogs
Honor & Awards:
My greatest honor: being Alyx's stepdad
Lee M Ellis, Houston TX
Lee M Ellis, Houston TX
Specialties:
Surgeon
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
University of Virginia, School of Medicine - Doctor of Medicine
Shands at the University of Florida - Residency - Surgery
Shands at the University of Florida - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Owner At Amos
Owner At Amos
Position:
Owner at Amos
Location:
Houston, Texas Area
Industry:
Design
Work:
Amos
-
Owner
Angiopoietin-1 In The Treatment Of Disease
Angiopoietin-1 In The Treatment Of Disease
US Patent:
2003022, Nov 27, 2003
Filed:
Feb 14, 2003
Appl. No.:
10/367259
Inventors:
Lee Ellis - Houston TX, US
International Classification:
A61K038/17, A61K048/00
US Classification:
514/012000, 514/044000
Abstract:
The present invention regards angiopoietin-1, which is a stabilizing factor for endothelial cells. The invention relates to angiopoietin-1 specifically as an inhibitor of tumor growth and angiogenesis, particularly for the treatment of cancer. In a particular embodiment, angiopoietin-1 is utilized to induce tumor dormancy or limit tumor growth by stabilizing the endothelium and preventing endothelial cell proliferation, and, thus, preventing angiogenesis.
Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use
Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use
US Patent:
2007019, Aug 23, 2007
Filed:
Feb 9, 2007
Appl. No.:
11/673052
Inventors:
Chun Li - Missouri City TX, US
Xiaoxia Wen - Houston TX, US
Qing-Ping Wu - Pearland TX, US
Sidney Wallace - Bellaire TX, US
Lee Ellis - Houston TX, US
Xiaoxia Wen - Houston TX, US
Qing-Ping Wu - Pearland TX, US
Sidney Wallace - Bellaire TX, US
Lee Ellis - Houston TX, US
International Classification:
A61K 51/06
US Classification:
424001490
Abstract:
Conjugate molecules comprising a ligand bonded to a polymer are disclosed. One such conjugate molecule comprises a ligand bonded to a polymer, a chelating agent bonded to the polymer, and a radioisotope chelated to the chelating agent. The conjugate molecules may be useful in detecting and/or treating tumors or biological receptors. These conjugate molecules may be synthesized without the necessity of preactivation of the ligand using an SCN-polymer-chelating agent precursor. Conjugate molecules incorporating an annexin V ligand are particularly useful for visualizing apoptotic cells. Conjugate molecules incorporating a C225 ligand are particularly useful for targeting tumors expressing EGFR.
Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use
Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use
US Patent:
2003000, Jan 2, 2003
Filed:
Apr 19, 2002
Appl. No.:
10/126216
Inventors:
Chun Li - Missouri City TX, US
Xiaoxia Wen - Houston TX, US
Qing-Ping Wu - Pearland TX, US
Sidney Wallace - Bellaire TX, US
Lee Ellis - Houston TX, US
Xiaoxia Wen - Houston TX, US
Qing-Ping Wu - Pearland TX, US
Sidney Wallace - Bellaire TX, US
Lee Ellis - Houston TX, US
International Classification:
A61K051/00, C07K016/46, C07H001/00, C07K014/00
US Classification:
424/001490, 530/391100, 536/123000, 530/350000
Abstract:
Conjugate molecules comprising a ligand bonded to a polymer are disclosed. One such conjugate molecule comprises a ligand bonded to a polymer, a chelating agent bonded to the polymer, and a radioisotope chelated to the chelating agent. The conjugate molecules may be useful in detecting and/or treating tumors or biological receptors. These conjugate molecules may be synthesized without the necessity of preactivation of the ligand using an SCN-polymer-chelating agent precursor. Conjugate molecules incorporating an annexin V ligand are particularly useful for visualizing apoptotic cells. Conjugate molecules incorporating a C225 ligand are particularly useful for targeting tumors expressing EGFR.